SK89599A3 - Rapidly releasing and taste-masking pharmaceutical dosage form - Google Patents

Rapidly releasing and taste-masking pharmaceutical dosage form Download PDF

Info

Publication number
SK89599A3
SK89599A3 SK895-99A SK89599A SK89599A3 SK 89599 A3 SK89599 A3 SK 89599A3 SK 89599 A SK89599 A SK 89599A SK 89599 A3 SK89599 A3 SK 89599A3
Authority
SK
Slovakia
Prior art keywords
weight
core
dosage form
coating layer
pharmaceutical dosage
Prior art date
Application number
SK895-99A
Other languages
English (en)
Slovak (sk)
Inventor
Akinori Itoh
Toshiyuki Niwa
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of SK89599A3 publication Critical patent/SK89599A3/sk

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • A61K9/1623Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5015Organic compounds, e.g. fats, sugars
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5026Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SK895-99A 1997-01-06 1997-11-20 Rapidly releasing and taste-masking pharmaceutical dosage form SK89599A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IB9700003 1997-01-06
PCT/IB1997/001471 WO1998030209A1 (fr) 1997-01-06 1997-11-20 Forme galenique pharmaceutique a liberation rapide et masquant le gout

Publications (1)

Publication Number Publication Date
SK89599A3 true SK89599A3 (en) 2000-12-11

Family

ID=11004515

Family Applications (1)

Application Number Title Priority Date Filing Date
SK895-99A SK89599A3 (en) 1997-01-06 1997-11-20 Rapidly releasing and taste-masking pharmaceutical dosage form

Country Status (36)

Country Link
EP (1) EP0941075B1 (fr)
JP (1) JP3350059B2 (fr)
KR (1) KR20000069899A (fr)
CN (1) CN1244119A (fr)
AP (1) AP802A (fr)
AR (1) AR008553A1 (fr)
AT (1) ATE238776T1 (fr)
AU (1) AU715867B2 (fr)
BG (1) BG103541A (fr)
BR (1) BR9714253A (fr)
CA (1) CA2277017C (fr)
CO (1) CO4650099A1 (fr)
DE (1) DE69721559T2 (fr)
DK (1) DK0941075T3 (fr)
EA (1) EA199900521A1 (fr)
ES (1) ES2192265T3 (fr)
HN (1) HN1997000151A (fr)
HR (1) HRP980005A2 (fr)
HU (1) HUP0002744A3 (fr)
ID (1) ID21806A (fr)
IL (1) IL130582A0 (fr)
IS (1) IS5095A (fr)
MA (1) MA26464A1 (fr)
NO (1) NO993315L (fr)
NZ (1) NZ336251A (fr)
OA (1) OA11072A (fr)
PA (1) PA8443301A1 (fr)
PE (1) PE27999A1 (fr)
PL (1) PL334439A1 (fr)
SK (1) SK89599A3 (fr)
TN (1) TNSN98002A1 (fr)
TR (1) TR199901564T2 (fr)
UY (1) UY24835A1 (fr)
WO (1) WO1998030209A1 (fr)
YU (1) YU31599A (fr)
ZA (1) ZA9829B (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6200591B1 (en) 1998-06-25 2001-03-13 Anwar A. Hussain Method of administration of sildenafil to produce instantaneous response for the treatment of erectile dysfunction
DE19834506A1 (de) * 1998-07-31 2000-02-03 Hexal Ag Transmucosales therapeutisches System zur Anwendung von Sildenafil
DE19834507A1 (de) * 1998-07-31 2000-02-03 Hexal Ag Pharmazeutische, wasserlösliche Tablettenformulierung zur Anwendung von Sildenafil
UA67802C2 (uk) 1998-10-23 2004-07-15 Пфайзер Рісьоч Енд Дівелепмент Компані, Н.В./С.А. Фармацевтична композиція з контрольованим вивільненням інгібітора цгмф фде-5 (варіанти), спосіб її одержання та спосіб лікування еректильної дисфункції
CA2351720C (fr) * 1998-11-25 2006-11-21 Cima Labs Inc. Systeme d'enrobage a liberation rapide masquant le gout
FR2795962B1 (fr) * 1999-07-08 2003-05-09 Prographarm Laboratoires Procede de fabrication de granules enrobes a gout masque et liberation immediate du principe actif
AU8444401A (en) 2000-09-06 2002-03-22 Tanabe Seiyaku Co Preparations for oral administration
GB0102342D0 (en) * 2001-01-30 2001-03-14 Smithkline Beecham Plc Pharmaceutical formulation
AR034813A1 (es) * 2001-07-20 2004-03-17 Novartis Ag Composiciones farmaceuticas y uso de las mismas
SE0202365D0 (sv) * 2002-08-05 2002-08-05 Pharmacia Ab New formulation and use thereof
BRPI0509062A (pt) 2004-03-25 2007-08-21 Astellas Pharma Inc composição para preparação farmacêutica sólida de solifenacina ou seu sal
BG66010B1 (bg) * 2004-12-08 2010-10-29 "Софарма" Ад Лекарствена форма на силденафил
EP1830814B1 (fr) * 2005-01-06 2009-07-01 Cima Labs Inc. Systeme de masquage de gout pour des medicaments non plastifiants
WO2007010930A1 (fr) * 2005-07-20 2007-01-25 Astellas Pharma Inc. Particule fine enrobee contenant un medicament pour une preparation se desagregeant dans la bouche et procede de production de celle-ci
US7815939B2 (en) 2005-07-20 2010-10-19 Astellas Pharma Inc. Coated fine particles containing drug for intrabuccally fast disintegrating dosage forms
JP2007031407A (ja) 2005-07-29 2007-02-08 Shin Etsu Chem Co Ltd 低置換度セルロースエーテル含有コーティング用組成物及び不快な味が隠蔽されたフィルムコーティング製剤
US20070098746A1 (en) * 2005-11-02 2007-05-03 Nichols William M Multi-layered coating technology for taste masking
JP4602949B2 (ja) * 2006-08-02 2010-12-22 和光堂株式会社 被覆粒子含有組成物及びその製造方法
CN101563064A (zh) * 2006-11-14 2009-10-21 新时代株式会社 含有用水溶性物质进行了表面处理的结晶纤维素的口腔用组合物
JP5777273B2 (ja) * 2008-07-10 2015-09-09 大正製薬株式会社 不快な呈味を有する薬物を含有する製剤粒子
JP4706785B2 (ja) * 2008-09-30 2011-06-22 アステラス製薬株式会社 経口投与用粒子状医薬組成物
BRPI0823356A2 (pt) 2008-12-12 2015-06-16 Rhein Siegfried Sa De Cv Composição de liberação pulsátil de sildenafil e processo para prepará-la
DE102009016584A1 (de) 2009-04-06 2010-10-07 Ratiopharm Gmbh Schmelztablette, enthaltend ein Sildenafil-Salz
WO2011081199A1 (fr) * 2009-12-28 2011-07-07 ニプロ株式会社 Préparation à usage oral améliorée en qualité
JP5226732B2 (ja) * 2010-05-20 2013-07-03 エスエス製薬株式会社 催眠用圧縮成型製剤
TWI462739B (zh) * 2010-11-02 2014-12-01 Univ Kaohsiung Medical Sildenafil-同族物四級銨哌嗪鹽類之製備及醫療用途
GB201119985D0 (en) * 2011-11-19 2012-01-04 Diurnal Ltd Treatment of adrenal insufficiency
CN103271940B (zh) * 2013-05-03 2014-03-12 湖北新济药业有限公司 复方金属离子补充剂及其制备方法
JP6905972B2 (ja) * 2016-02-23 2021-07-21 ニプロ株式会社 医薬組成物粒子とそれを含む口腔内崩壊製剤、医薬組成物粒子の製造方法
JPWO2020045456A1 (ja) * 2018-08-28 2021-08-10 東和薬品株式会社 薬物含有粒子
CN113559070B (zh) * 2021-08-18 2022-12-06 广州中冠动物药业有限公司 一种适用于宠物咳嗽的药物制备方法
CN116139088B (zh) * 2023-01-31 2024-04-16 南京海纳医药科技股份有限公司 一种含有枸橼酸西地那非的干混悬剂及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63258809A (ja) * 1987-04-16 1988-10-26 Towa Yakuhin Kk 医薬活性成分の放出性にすぐれ、かつ苦味を隠蔽した細粒剤
EP0458751A1 (fr) * 1990-05-25 1991-11-27 Warner-Lambert Company Système à libération d'amino-acides cycliques avec gôut, texture et compressibilité améliorés
JP2576927B2 (ja) * 1992-05-15 1997-01-29 ファイザー製薬株式会社 細粒核
PT1078628E (pt) * 1994-07-08 2009-01-27 Astrazeneca Ab Forma de dosagem em comprimidos com unidades múltiplas

Also Published As

Publication number Publication date
BR9714253A (pt) 2000-04-18
YU31599A (sh) 2000-03-21
AU715867B2 (en) 2000-02-10
TR199901564T2 (xx) 1999-09-21
OA11072A (en) 2002-02-27
HRP980005A2 (en) 1998-10-31
HN1997000151A (es) 1997-12-20
CN1244119A (zh) 2000-02-09
EP0941075A1 (fr) 1999-09-15
ID21806A (id) 1999-07-29
CO4650099A1 (es) 1998-09-03
IS5095A (is) 1999-06-25
AP802A (en) 2000-01-21
HUP0002744A2 (hu) 2000-12-28
DK0941075T3 (da) 2003-07-14
EP0941075B1 (fr) 2003-05-02
PL334439A1 (en) 2000-02-28
NO993315D0 (no) 1999-07-05
ZA9829B (en) 1999-07-05
HUP0002744A3 (en) 2001-01-29
NO993315L (no) 1999-07-05
PA8443301A1 (es) 2000-05-24
ES2192265T3 (es) 2003-10-01
MA26464A1 (fr) 2004-12-20
DE69721559D1 (de) 2003-06-05
NZ336251A (en) 2001-01-26
CA2277017A1 (fr) 1998-07-16
UY24835A1 (es) 2000-09-29
CA2277017C (fr) 2002-11-26
WO1998030209A1 (fr) 1998-07-16
BG103541A (en) 2000-03-31
AU4880897A (en) 1998-08-03
TNSN98002A1 (fr) 2005-03-15
JP3350059B2 (ja) 2002-11-25
AR008553A1 (es) 2000-01-19
DE69721559T2 (de) 2003-11-27
ATE238776T1 (de) 2003-05-15
EA199900521A1 (ru) 1999-12-29
PE27999A1 (es) 1999-03-12
KR20000069899A (ko) 2000-11-25
IL130582A0 (en) 2000-06-01
AP9801173A0 (en) 1998-01-31
JP2000514830A (ja) 2000-11-07

Similar Documents

Publication Publication Date Title
US6221402B1 (en) Rapidly releasing and taste-masking pharmaceutical dosage form
SK89599A3 (en) Rapidly releasing and taste-masking pharmaceutical dosage form
US11452689B2 (en) Taste-masked pharmaceutical compositions
JP5808670B2 (ja) 弱塩基性薬物を含む組成物及び徐放性剤形
EP1802285B1 (fr) Compositions pharmaceutiques a saveur masquee avec substances porogenes gastrosolubles
JP5854476B2 (ja) 圧縮性コーティングで被覆された医薬組成物及び錠剤並びに製造方法
US8747895B2 (en) Orally disintegrating tablets of atomoxetine
US20060204587A1 (en) Use of film coating as taste-masking coating of oral dosage forms
EP0281513A1 (fr) Pellets gonflables
CN102026627A (zh) 口腔崩解固体制剂
AU2005307052A1 (en) Taste-masked multiparticulate pharmaceutical compositions comprising a drug-containing core particle and a solvent-coacervated membrane
TWI483748B (zh) 含有氫嗎啡酮(hydromorphone)和納洛酮(naloxone)之藥學組成物
CA2630235A1 (fr) Comprimes a desintegration orale de lansoprazole
EP1581197A1 (fr) Composition pour enrobage de masquage de gout et procedes d'application de ladite composition
WO2009102830A1 (fr) Compositions de comprimés de ranitidine se délitant oralement et leurs procédés de fabrication
US20070154550A1 (en) Pharmaceutical composition comprising anticonvulsant with taste mask coating
CZ235799A3 (cs) Farmaceutická dávkovači forma s rychlým uvolňováním a maskující chuť a způsob její výroby
ZA200506028B (en) Composition comprising a mixture of active principles, and method of preparation